Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 252061 - 252080 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Greece | (L01EA01) imatinib (adm: O) | IMATINIB TEVA F.C.TAB 100MG/TAB BTx60 σε PVC/PE/PVDC/PE/PVC/AL BLISTER | n/a | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Myelodysplastic-Myeloproliferative Diseases;Hypereosinophilic Syndrome;Dermatofibrosarcoma | TEVAB.V.,THENETHERLANDS |
| Greece | (L01EA01) imatinib (adm: O) | IMATINIB/AENORASIS F.C.TAB 100MG/TAB BTx60 (PVC/PE/PVDC/Alu Blisters) | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | ΕΝΟΡΑΣΙΣΑΕ |
| Greece | (L01EA01) imatinib (adm: O) | GLIVEC F.C.TAB 400MG/TAB BTX30 | n/a | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Gastrointestinal Stromal Tumors;Dermatofibrosarcoma;Myelodysplastic-Myeloproliferative Diseases;Leukemia, Myelogenous, Chronic, BCR-ABL Positive;Hypereosinophilic Syndrome | NOVARTISEUROPHARMLIMITED,IRELAND |
| Greece | (L01EA01) imatinib (adm: O) | IMATINIB TEVA F.C.TAB 400MG/TAB BTx30 σε PVC/PE/PVDC/PE/PVC/AL BLISTER | n/a | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Myelodysplastic-Myeloproliferative Diseases;Hypereosinophilic Syndrome;Dermatofibrosarcoma | TEVAB.V.,THENETHERLANDS |
| Greece | (L01EA01) imatinib (adm: O) | IMATINIB/AENORASIS F.C.TAB 400MG/TAB BTx30 (PVC/PE/PVDC/Alu Blisters) | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | ΕΝΟΡΑΣΙΣΑΕ |
| Greece | (L01EA02) dasatinib (adm: O) | DASATINIB/FARAN F.C.TAB 100MG/TAB BTx30 tabs (σε blister OPA/AL/PVC/AL) | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | ΦΑΡΑΝΑΝΩΝΥΜΗΒΙΟΜΗΧΑΝΙΚΗΚΑΙΕΜΠΟΡΙΚΗΕΤΑΙΡΕΙΑΠΑΡΑΓΩΓΗΣΚΑΙΕΜΠΟΡΙΑΣΦΑΡΜΑΚΩΝΔ.Τ.ΦΑΡΑΝΑ.Β.Ε.Ε. |
| Greece | (L01EA02) dasatinib (adm: O) | DASATINIB/TEVA F.C.TAB 100MG/TAB BT X 30 F.C.TAB ΣΕ HDPE ΦΙΑΛΗ ΠΟΥ ΠΕΡΙΕΧΕΙ ΑΦΥΓΡΑΝΤΙΚΟ ΚΑΙ ΠΩΜΑ ΑΣΦΑΛΕΙΑΣ ΑΠΟ ΠΟΛΥΠΡΟΠΥΛΕΝΙΟ | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | TEVAB.V.,THENETHERLANDS |
| Greece | (L01EA02) dasatinib (adm: O) | SPRYCEL F.C.TAB 100MG/TAB BTx 30 BOTTLE (HDPE) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | BRISTOL-MYERSSQUIBBPHARMAEEIG,IRELAND |
| Greece | (L01EA02) dasatinib (adm: O) | DASATINIB/FARAN F.C.TAB 20MG/TAB BTx60 tabs (σε blister OPA/AL/PVC/AL) | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | ΦΑΡΑΝΑΝΩΝΥΜΗΒΙΟΜΗΧΑΝΙΚΗΚΑΙΕΜΠΟΡΙΚΗΕΤΑΙΡΕΙΑΠΑΡΑΓΩΓΗΣΚΑΙΕΜΠΟΡΙΑΣΦΑΡΜΑΚΩΝΔ.Τ.ΦΑΡΑΝΑ.Β.Ε.Ε. |
| Greece | (L01EA02) dasatinib (adm: O) | DASATINIB/TEVA F.C.TAB 20MG/TAB BT X 60 F.C.TAB ΣΕ HDPE ΦΙΑΛΗ ΠΟΥ ΠΕΡΙΕΧΕΙ ΑΦΥΓΡΑΝΤΙΚΟ ΚΑΙ ΠΩΜΑ ΑΣΦΑΛΕΙΑΣ ΑΠΟ ΠΟΛΥΠΡΟΠΥΛΕΝΙΟ | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | TEVAB.V.,THENETHERLANDS |
| Greece | (L01EA02) dasatinib (adm: O) | SPRYCEL F.C.TAB 20mg/TAB BOTTLE (HDPE x 60) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | BRISTOL-MYERSSQUIBBPHARMAEEIG,IRELAND |
| Greece | (L01EA02) dasatinib (adm: O) | DASATINIB/FARAN F.C.TAB 50MG/TAB BTx60 tabs (σε blister OPA/AL/PVC/AL) | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | ΦΑΡΑΝΑΝΩΝΥΜΗΒΙΟΜΗΧΑΝΙΚΗΚΑΙΕΜΠΟΡΙΚΗΕΤΑΙΡΕΙΑΠΑΡΑΓΩΓΗΣΚΑΙΕΜΠΟΡΙΑΣΦΑΡΜΑΚΩΝΔ.Τ.ΦΑΡΑΝΑ.Β.Ε.Ε. |
| Greece | (L01EA02) dasatinib (adm: O) | DASATINIB/TEVA F.C.TAB 50MG/TAB BT X 60 F.C.TAB ΣΕ HDPE ΦΙΑΛΗ ΠΟΥ ΠΕΡΙΕΧΕΙ ΑΦΥΓΡΑΝΤΙΚΟ ΚΑΙ ΠΩΜΑ ΑΣΦΑΛΕΙΑΣ ΑΠΟ ΠΟΛΥΠΡΟΠΥΛΕΝΙΟ | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | TEVAB.V.,THENETHERLANDS |
| Greece | (L01EA02) dasatinib (adm: O) | SPRYCEL F.C.TAB 50MG/TAB BOTTLE (HDPEx60) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | BRISTOL-MYERSSQUIBBPHARMAEEIG,IRELAND |
| Greece | (L01EA02) dasatinib (adm: O) | DASATINIB/FARAN F.C.TAB 70MG/TAB BTx60 tabs (σε blister OPA/AL/PVC/AL) | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | ΦΑΡΑΝΑΝΩΝΥΜΗΒΙΟΜΗΧΑΝΙΚΗΚΑΙΕΜΠΟΡΙΚΗΕΤΑΙΡΕΙΑΠΑΡΑΓΩΓΗΣΚΑΙΕΜΠΟΡΙΑΣΦΑΡΜΑΚΩΝΔ.Τ.ΦΑΡΑΝΑ.Β.Ε.Ε. |
| Greece | (L01EA02) dasatinib (adm: O) | DASATINIB/TEVA F.C.TAB 70MG/TAB BT X 60 F.C.TAB ΣΕ HDPE ΦΙΑΛΗ ΠΟΥ ΠΕΡΙΕΧΕΙ ΑΦΥΓΡΑΝΤΙΚΟ ΚΑΙ ΠΩΜΑ ΑΣΦΑΛΕΙΑΣ ΑΠΟ ΠΟΛΥΠΡΟΠΥΛΕΝΙΟ | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | TEVAB.V.,THENETHERLANDS |
| Greece | (L01EA02) dasatinib (adm: O) | SPRYCEL F.C.TAB 70MG/TAB BOTTLE (HDPE x 60) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | BRISTOL-MYERSSQUIBBPHARMAEEIG,IRELAND |
| Greece | (L01EA03) nilotinib (adm: O) | TASIGNA CAPS 150MG/CAP BTx112 σε BLIST (PVC/PVDC/AL) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NOVARTISEUROPHARMLIMITED,IRELAND |
| Greece | (L01EA03) nilotinib (adm: O) | TASIGNA CAPS 200MG/CAP BLISTx112 (PVC/PVDC/AL) σε χάρτινο κουτί | n/a | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NOVARTISEUROPHARMLIMITED,IRELAND |
| Greece | (L01EA04) bosutinib (adm: O) | BOSULIF F.C.TAB 500MG/TAB BTx28 σε BLISTERS (PVC/ACLAR/PVC) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | PFIZEREUROPEMAEEIG,BELGIUM |
Pages
